Promomed's revenue for 6 months of 2025 amounted to ₽13 billion, an increase of 82% compared to last year. Share of revenue from the sale of innovative products increased by 3 percentage points, to 60%. In the endocrinology segment, revenue increased 2.2 times to ₽4.8 billion. In the oncology segment, revenue increased 2.9 times and reached ₽4.7 billion.